JTp and Tpe as Biomarkers of proarrhythmic risk in nonclinical models: Historical data evaluation by the HESI consortium.

MLA

Gendron-Parra, Nicolas, et al. “JTp and Tpe as Biomarkers of Proarrhythmic Risk in Nonclinical Models: Historical Data Evaluation by the HESI Consortium.” Journal of Pharmacological & Toxicological Methods, vol. 99, Sept. 2019, p. 121. EBSCOhost, https://doi.org/10.1016/j.vascn.2018.01.412.

APA

Gendron-Parra, N., Abernathy, M. M., Boulay, E., Chui, R., Friedrichs, G. S., Greiter-Wilke, A., Guillon, J., Leishman, D. J., Nichols, J., Pierson, J., Skinner, M., Pugsley, M. K., Valentin, J.-P., Vargas, H. M., & Authier, S. (2019). JTp and Tpe as Biomarkers of proarrhythmic risk in nonclinical models: Historical data evaluation by the HESI consortium. Journal of Pharmacological & Toxicological Methods, 99, 121. https://doi.org/10.1016/j.vascn.2018.01.412

Chicago

Gendron-Parra, Nicolas, Matthew M. Abernathy, Emmanuel Boulay, Ray Chui, Gregory S. Friedrichs, Andrea Greiter-Wilke, Jean-michel Guillon, et al. 2019. “JTp and Tpe as Biomarkers of Proarrhythmic Risk in Nonclinical Models: Historical Data Evaluation by the HESI Consortium.” Journal of Pharmacological & Toxicological Methods 99 (September): 121. doi:10.1016/j.vascn.2018.01.412.